China Medicine Corporation
CHME · OTC
9/30/2010 | 6/30/2010 | 3/31/2010 | 12/31/2009 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 2.1% | 62.6% | -48.3% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 33.1% | 35.5% | 30.7% | 33.5% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 16.6% | 24.8% | 16.2% | 22.2% |
| Net Income | $0 | $0 | $0 | -$0 |
| % Margin | 12.7% | 23.9% | 17% | -10.2% |
| EPS Diluted | 0.06 | 0.1 | -0.23 | -0.14 |
| % Growth | -40% | 143.5% | -64.3% | – |
| Operating Cash Flow | -$0 | -$0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | $0 |
| Free Cash Flow | -$0 | -$0 | $0 | $0 |